Matches in SemOpenAlex for { <https://semopenalex.org/work/W2600668052> ?p ?o ?g. }
Showing items 1 to 80 of
80
with 100 items per page.
- W2600668052 abstract "3644 Background: Recent work has shown an association between longer survival and aspirin use in colorectal cancer (CRC) patients with mutated PIK3CA. It has been hypothesized that this survival advantage could occur via blocking the PI3K pathway and allowing apoptosis of mutated cancer cells. The goal of this work is examine the use of aspirin and outcome in CRC patients with PI3KCA mutation. Methods: PIK3CA mutation status was assessed in paraffin-embedded tumor samples from 471 CRC patients between 1998-2010. PIK3CA mutation was assessed by exome sequencing using an Illumina Next Generation (NGS) platform with 50-100X coverage on all patients. The BWA/GATK pipeline was used to identify variants and indels. Because matched normal samples were not available for comparison to identify somatic mutations, filtering of normal variants was performed using 1000 Genomes. The usage of aspirin was collected retrospectively with electronic chart review. Results: Out of 471 patients, 73 were found to have unique PIK3CA mutations by NGS (15.4%). The most common mutations were found at codon 9 (38%) and codon 20 (21%). Patients had a median follow up of 47 months. Initial stage at diagnosis for PIK3CA mutants were as follows: 11 pts were stage I, 31 pts were stage II, 24 pts were stage III and 16 patients were stage IV. Of patients who died, those taking ASA had a 5% cancer related mortality compared to 23% cancer related mortality in non-ASA users. In contrast, the non-cancer related mortality was 25% in ASA users and only 8% in non-ASA users. Cancer specific rates for five year survival were 90% in the ASA group and 57% in the non-ASA group for all stages. In stage IV patients, there was 80% five year survival in the ASA users and 32% in the non-ASA group. Conclusions: There was a trend toward improvement in five year survival for colorectal cancer patients with PIK3CA mutations who used ASA. This trend persisted even in stage IV patients. Notably, non-cancer related deaths were higher in the ASA users, most likely secondary to medical comorbidities that necessitated ASA use. As follow up continues and this data set matures, future work will focus on validating these preliminary results and relating specific PIK3CA mutations to ASA response." @default.
- W2600668052 created "2017-04-07" @default.
- W2600668052 creator A5045482037 @default.
- W2600668052 creator A5050278861 @default.
- W2600668052 creator A5053957826 @default.
- W2600668052 creator A5054183176 @default.
- W2600668052 creator A5055925608 @default.
- W2600668052 date "2013-05-20" @default.
- W2600668052 modified "2023-09-27" @default.
- W2600668052 title "Association of aspirin use with improved 5-year survival in colorectal cancer patients with PIK3CA mutation." @default.
- W2600668052 doi "https://doi.org/10.1200/jco.2013.31.15_suppl.3644" @default.
- W2600668052 hasPublicationYear "2013" @default.
- W2600668052 type Work @default.
- W2600668052 sameAs 2600668052 @default.
- W2600668052 citedByCount "0" @default.
- W2600668052 crossrefType "journal-article" @default.
- W2600668052 hasAuthorship W2600668052A5045482037 @default.
- W2600668052 hasAuthorship W2600668052A5050278861 @default.
- W2600668052 hasAuthorship W2600668052A5053957826 @default.
- W2600668052 hasAuthorship W2600668052A5054183176 @default.
- W2600668052 hasAuthorship W2600668052A5055925608 @default.
- W2600668052 hasConcept C104317684 @default.
- W2600668052 hasConcept C10590036 @default.
- W2600668052 hasConcept C119054055 @default.
- W2600668052 hasConcept C121608353 @default.
- W2600668052 hasConcept C126322002 @default.
- W2600668052 hasConcept C135763542 @default.
- W2600668052 hasConcept C143998085 @default.
- W2600668052 hasConcept C153209595 @default.
- W2600668052 hasConcept C16671776 @default.
- W2600668052 hasConcept C2777628954 @default.
- W2600668052 hasConcept C2781187634 @default.
- W2600668052 hasConcept C501734568 @default.
- W2600668052 hasConcept C526805850 @default.
- W2600668052 hasConcept C54355233 @default.
- W2600668052 hasConcept C71924100 @default.
- W2600668052 hasConcept C86803240 @default.
- W2600668052 hasConceptScore W2600668052C104317684 @default.
- W2600668052 hasConceptScore W2600668052C10590036 @default.
- W2600668052 hasConceptScore W2600668052C119054055 @default.
- W2600668052 hasConceptScore W2600668052C121608353 @default.
- W2600668052 hasConceptScore W2600668052C126322002 @default.
- W2600668052 hasConceptScore W2600668052C135763542 @default.
- W2600668052 hasConceptScore W2600668052C143998085 @default.
- W2600668052 hasConceptScore W2600668052C153209595 @default.
- W2600668052 hasConceptScore W2600668052C16671776 @default.
- W2600668052 hasConceptScore W2600668052C2777628954 @default.
- W2600668052 hasConceptScore W2600668052C2781187634 @default.
- W2600668052 hasConceptScore W2600668052C501734568 @default.
- W2600668052 hasConceptScore W2600668052C526805850 @default.
- W2600668052 hasConceptScore W2600668052C54355233 @default.
- W2600668052 hasConceptScore W2600668052C71924100 @default.
- W2600668052 hasConceptScore W2600668052C86803240 @default.
- W2600668052 hasLocation W26006680521 @default.
- W2600668052 hasOpenAccess W2600668052 @default.
- W2600668052 hasPrimaryLocation W26006680521 @default.
- W2600668052 hasRelatedWork W2008560339 @default.
- W2600668052 hasRelatedWork W2024796296 @default.
- W2600668052 hasRelatedWork W2046687780 @default.
- W2600668052 hasRelatedWork W2103496142 @default.
- W2600668052 hasRelatedWork W2125955619 @default.
- W2600668052 hasRelatedWork W2165194477 @default.
- W2600668052 hasRelatedWork W2470900586 @default.
- W2600668052 hasRelatedWork W2476238721 @default.
- W2600668052 hasRelatedWork W2519507649 @default.
- W2600668052 hasRelatedWork W2521392383 @default.
- W2600668052 hasRelatedWork W2756802707 @default.
- W2600668052 hasRelatedWork W2894398934 @default.
- W2600668052 hasRelatedWork W2902449607 @default.
- W2600668052 hasRelatedWork W2934891072 @default.
- W2600668052 hasRelatedWork W2940852996 @default.
- W2600668052 hasRelatedWork W3006571870 @default.
- W2600668052 hasRelatedWork W3087357516 @default.
- W2600668052 hasRelatedWork W3087429366 @default.
- W2600668052 hasRelatedWork W3177058874 @default.
- W2600668052 hasRelatedWork W3203431203 @default.
- W2600668052 isParatext "false" @default.
- W2600668052 isRetracted "false" @default.
- W2600668052 magId "2600668052" @default.
- W2600668052 workType "article" @default.